Site-directed <it>in vitro </it>immunization leads to a complete human monoclonal IgG4λ that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands
<p>Abstract</p> <p>Background</p> <p>The ability to acquire fully human monoclonal antibodies (mAbs) with pre-defined specificities is critical to the development of molecular tags for the analysis of receptor function in addition to promising immunotherapeutics. Yet mo...
Main Authors: | Hsu Shu-Ching, Chen Han-Min, Chu Chishih, Chin Li-Te, Weng Bor-Chun, Chu Chi-Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-08-01
|
Series: | BMC Biotechnology |
Online Access: | http://www.biomedcentral.com/1472-6750/7/51 |
Similar Items
-
Scleredema accompanied by IgG‐λ monoclonal gammopathy
by: Haruka Goto, et al.
Published: (2019-08-01) -
CD152 (CTLA-4) determines CD4 T cell migration in vitro and in vivo.
by: Karin Knieke, et al.
Published: (2009-05-01) -
Study of the regulatory receptor CTLA-4 (CD152) in human myeloid derived cells
by: Elzatma, Essameddin
Published: (2009) -
Effects of CTLA4-Ig on human monocytes
by: Toshihiro Tono, et al.
Published: (2017-11-01) -
Proliferative Glomerulonephritis With Monoclonal IgG3λ Deposits: A Case Report of a Rare Cause of Monoclonal Gammopathy of Renal Significance
by: Xiao-juan Yu, et al.
Published: (2019-07-01)